Brief: Lisata Therapeutics Announces First Patient Treated In Phase 2A Trial Of Lsta1
17/01/2024 13:24
Jan 17 (Reuters) - Lisata Therapeutics Inc LSTA.O :
* LISATA THERAPEUTICS ANNOUNCES FIRST PATIENT TREATED IN THE
PHASE
2A TRIAL OF LSTA1 IN PATIENTS WITH GLIOBLASTOMA MULTIFORME
Source text for Eikon: ID:nGNXKYmn2
Further company coverage: LSTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lisata Therapeutics
See all newsBrief: Lisata Therapeutics - Amends Merger Offer Price To $4 Per Share Plus CVR
Brief: Lisata Therapeutics Enters Into Definitive Agreement To Be Acquired By Kuva Labs, Inc.
U.S. STOCKS ON THE MOVE-Oklo, AMD, Lam Research
U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies
Lisata jumps as Kuva Labs strikes acquisition deal